chr17-80353538-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001256071.3(RNF213):​c.10450G>A​(p.Gly3484Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000793 in 1,613,088 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00082 ( 1 hom. )

Consequence

RNF213
NM_001256071.3 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.754

Publications

6 publications found
Variant links:
Genes affected
RNF213 (HGNC:14539): (ring finger protein 213) This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
RNF213-AS1 (HGNC:54402): (RNF213 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011791825).
BP6
Variant 17-80353538-G-A is Benign according to our data. Variant chr17-80353538-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2864517.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000552 (84/152282) while in subpopulation AMR AF = 0.00177 (27/15286). AF 95% confidence interval is 0.00125. There are 0 homozygotes in GnomAd4. There are 33 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256071.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNF213
NM_001256071.3
MANE Select
c.10450G>Ap.Gly3484Ser
missense
Exon 34 of 68NP_001243000.2A0A0A0MTR7
RNF213
NM_001410195.1
c.10597G>Ap.Gly3533Ser
missense
Exon 35 of 69NP_001397124.1A0A0A0MTC1
RNF213
NM_020914.5
c.10597G>Ap.Gly3533Ser
missense
Exon 35 of 69NP_065965.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNF213
ENST00000582970.6
TSL:1 MANE Select
c.10450G>Ap.Gly3484Ser
missense
Exon 34 of 68ENSP00000464087.1A0A0A0MTR7
RNF213
ENST00000508628.6
TSL:5
c.10597G>Ap.Gly3533Ser
missense
Exon 35 of 69ENSP00000425956.2A0A0A0MTC1
RNF213-AS1
ENST00000575034.5
TSL:2
n.1941C>T
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.000552
AC:
84
AN:
152166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000691
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000437
AC:
108
AN:
247200
AF XY:
0.000366
show subpopulations
Gnomad AFR exome
AF:
0.000125
Gnomad AMR exome
AF:
0.000379
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000466
Gnomad NFE exome
AF:
0.000804
Gnomad OTH exome
AF:
0.000493
GnomAD4 exome
AF:
0.000818
AC:
1195
AN:
1460806
Hom.:
1
Cov.:
30
AF XY:
0.000809
AC XY:
588
AN XY:
726598
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33474
American (AMR)
AF:
0.000764
AC:
34
AN:
44478
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86068
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53342
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00101
AC:
1121
AN:
1111526
Other (OTH)
AF:
0.000547
AC:
33
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
62
124
186
248
310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000552
AC:
84
AN:
152282
Hom.:
0
Cov.:
33
AF XY:
0.000443
AC XY:
33
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41572
American (AMR)
AF:
0.00177
AC:
27
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000691
AC:
47
AN:
68020
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000688
Hom.:
0
Bravo
AF:
0.000914
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000395
AC:
48

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.64
DANN
Benign
0.61
DEOGEN2
Benign
0.0041
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.75
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.019
Sift
Benign
0.70
T
Sift4G
Benign
0.21
T
Vest4
0.024
MVP
0.076
MPC
0.34
ClinPred
0.018
T
GERP RS
-1.8
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.1
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140300282; hg19: chr17-78327338; API